STAT3 and B-cell chronic lymphocytic leukemia: Additionally, treatment with Bis-I, a PKC inhibitor also suppressed p-STAT3-S727 and p-STAT3-Y705 levels in both JVM-3 cells (Figure 5c(ii)) and CLL patient cells (Figure 5c(iii)).